Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network). Harari S, et al. Among authors: agostini c. Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999. Clin Respir J. 2019. PMID: 30675755 Free article.
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.
Harari S, Caminati A, Albera C, Vancheri C, Poletti V, Pesci A, Luppi F, Saltini C, Agostini C, Bargagli E, Sebastiani A, Sanduzzi A, Giunta V, Della Porta R, Bandelli GP, Puglisi S, Tomassetti S, Biffi A, Cerri S, Mari A, Cinetto F, Tirelli F, Farinelli G, Bocchino M, Specchia C, Confalonieri M. Harari S, et al. Among authors: agostini c. Respir Med. 2015 Jul;109(7):904-13. doi: 10.1016/j.rmed.2015.04.010. Epub 2015 Apr 25. Respir Med. 2015. PMID: 25962649 Free article.
The broad spectrum of lung diseases in primary antibody deficiencies.
Cinetto F, Scarpa R, Rattazzi M, Agostini C. Cinetto F, et al. Among authors: agostini c. Eur Respir Rev. 2018 Aug 29;27(149):180019. doi: 10.1183/16000617.0019-2018. Print 2018 Sep 30. Eur Respir Rev. 2018. PMID: 30158276 Free PMC article. Review.
Rare pulmonary diseases: a path to the future.
Harari S, Agostini C. Harari S, et al. Among authors: agostini c. Respir Med. 2010 Jul;104 Suppl 1:S1. doi: 10.1016/j.rmed.2010.03.011. Epub 2010 Apr 28. Respir Med. 2010. PMID: 20427171 Free article. No abstract available.
New frontiers for rare pulmonary diseases.
Agostini C, Harari S. Agostini C, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S1-3. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 16457010
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.
Pulvirenti F, Cinetto F, Pecoraro A, Carrabba M, Crescenzi L, Neri R, Bonanni L, Fabio G, Agostini C, Spadaro G, Tabolli S, Farrugia A, Quinti I, Milito C. Pulvirenti F, et al. Among authors: agostini c. J Clin Immunol. 2019 Feb;39(2):159-170. doi: 10.1007/s10875-019-0592-5. Epub 2019 Jan 15. J Clin Immunol. 2019. PMID: 30644015 Free PMC article.
478 results